|
 |
|
|
|||
|
 |
|
 Jan. 16, 2023 by Shane Thomas, Upstream Ag Insights newsletter This week a couple activist investors purchased significant stakes in Bayer, with the view that there is a need to split out the agriculture businesses from the consumer health and pharmaceutical business. For financial background, Bayer purchased Monsanto for $63 billion USD. At the beginning of 2018 before the close of the deal, Bayer had a market capitalization of over $100 billion USD. When the Monsanto deal closed, Bayer shed 30% of its value within weeks of the close due to the glyphosate lawsuits. It has only went down from there. Before the activist investor purchases increased the stock price, the market capitalization was about $55 billion USD in early January 2023 showing an almost 50% decline in value since the acquisition, with the decline almost equalling the entire cost of the acquisition and Bayer now being worth LESS in totality than what they paid for Monsanto. To read the entire report https://www.bnnbloomberg.ca/activist-investor-jeff-ubben-acquires-stake-in-germany-s-bayer-1.1867647">click here.Ac Tweet |
|
|
|
|
|
|
|
|
|||||||||||||
